What Canopy Growth does

Canopy Growth Corporation is a Canadian publicly traded cannabis consumer products company (TSX: WEED, NASDAQ: CGC) headquartered in Smiths Falls, Ontario, with operations spanning medical cannabis cultivation, recreational cannabis branded products, medical vaporizer devices, and pharmaceutical manufacturing. Founded in 2003, the company operates a portfolio of more than 15 cannabis brands including Tweed (flagship consumer brand), 7Acres (premium flower), Doja (craft), Deep Space (high-potency beverages and gummies), Wana (edibles), Twd. and Deelish (value segments), and Spectrum Therapeutics (international medical). It also owns Storz & Bickel, a German manufacturer of medical-grade vaporizers including the Volcano Medic 2 with ISO 13485 certification, and Canopy Medical, a German pharmaceutical manufacturer for medical cannabis products. Distribution reaches Canada (provincial retailers plus company-owned Tweed and Tokyo Smoke stores), Germany (the largest European medical cannabis market), UK, Poland, Czech Republic, and Australia, with the company claiming product availability in over 50 countries.

The company generates revenue primarily through one-time product sales of dried cannabis flower, pre-rolls, vape cartridges, edibles, beverages, gummies, and softgels across Canadian recreational and medical markets plus international medical cannabis channels, supplemented by hardware sales of vaporizer devices and professional services revenue from Apollo Cannabis Clinics virtual consultations and Canada House clinics acquired through MTL Cannabis. Canopy operates over 10.5 million square feet of cultivation capacity including over 1 million square feet GMP-certified, and recently completed the acquisition of MTL Cannabis Corp. for approximately $125 million CAD in March 2026, which is expected to deliver $10 million in annualized synergies within 18 months. The company has undergone significant financial restructuring, moving from a net debt position of $172.6 million to a net cash position of $131.3 million through a January 2026 recapitalization that included a $150 million USD term loan and extension of all debt maturities to at least January 2031, with management targeting positive adjusted EBITDA by FY2027.

Constellation Brands holds approximately 38.6% of common shares as the largest shareholder following cumulative investments exceeding C$5 billion. FY2026 net revenue was $284.6 million (6% growth YoY), with notable momentum in Canadian medical cannabis (27% Q4 YoY growth) and international markets (68% Q4 YoY growth). The company is pursuing U.S. market entry through Canopy USA contingent on federal THC permissibility, leveraging its Acreage Holdings option arrangement, and faces a Management Cease Trade Order from the Ontario Securities Commission requiring restatement of FY2024 and FY2025 results due to non-cash warrant accounting issues.

Name

Canopy Growth

Legal name

Canopy Growth Corporation

Website

https://canopygrowth.com

Company type

Public

Founded year

2003

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Canopy Growth is a Canadian publicly traded cannabis company that manufactures and sells medical and recreational cannabis products, medical vaporizers, and cannabis-infused consumer goods across Canada, Germany, and other international markets through a portfolio of 15+ brands.

Ownership category

akta.pro rank

Product category

Cannabis Products

NAICS

Tobacco Manufacturing (3122)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail) (CRANAFAG)

akta.pro secondary industries

Cannabis Dispensary + Ancillary Retail (Accessories, CBD/Hemp, Merchandise) (CRANAFAH), Dispensary-Owned Online Ordering & Delivery (Direct-to-Consumer) (CRANAGAE), Cannabis Accessories & Smoke Shops (Pipes, Papers, Grinders) (CRANAHAG)

Keywords

• Cannabis products
• Medical cannabis
• Cannabis cultivation
• Vaporizer devices
• Cannabis brands

Headquarters

HQ city

Smiths Falls

HQ country

Canada

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Cannabis Product Sales: Revenue from selling dried cannabis flower, pre-rolls, vape cartridges, edibles, beverages, and gummies through Canadian recreational and medical markets, as well as international medical cannabis markets
2. Medical Device Sales (Storz & Bickel): Revenue from manufacturing and selling vaporizer devices for medical and consumer use, including Volcano, Crafty, and Mighty product lines
3. Cultivation Services: Revenue from medical cannabis cultivation and processing, including premium flower production through MTL Cannabis facilities serving Canadian and international markets
4. Medical Cannabis Clinics: Revenue from Apollo Cannabis Clinics providing virtual medical cannabis consultations across Canada

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Canopy Growth is a diversified cannabis company that cultivates, manufactures, and sells cannabis products—including dried flower, pre-rolls, vape cartridges, edibles, beverages, and softgels—through a portfolio of 15+ brands across Canadian recreational, Canadian medical, and international medical cannabis markets. The company also produces medical-grade vaporizer devices through its Storz & Bickel subsidiary and operates virtual medical cannabis clinics through Apollo Cannabis Clinics and Canada House Clinics.

Product overview

Canopy Growth is a diversified cannabis company operating a multi-brand portfolio across recreational and medical cannabis segments. The product portfolio spans multiple categories including dried flower, pre-rolls, vape cartridges, beverages, gummies, softgels, and medical devices. Core Canadian consumer brands include Tweed (flagship), 7Acres (premium flower), Doja (craft), Deep Space (beverages), Wana (gummies), Hiway (value), and Twd. (affordable simple products). Medical cannabis is served through Spectrum Therapeutics internationally and Apollo Cannabis Clinics in Canada. The company also owns Storz & Bickel, a leading vaporizer manufacturer producing medical-grade devices including Volcano Medic 2. The recent acquisition of MTL Cannabis added premium flower cultivation capabilities and medical clinic operations (Canada House). Products range from budget/value offerings (Deelish, Twd.) to premium/specialty tiers (Doja, 7Acres, Claybourne), with the Storz & Bickel subsidiary providing medical device technology across multiple regulated markets.

Differentiator

Problem solved

Functional benefit

Brands

• Apollo Cannabis Clinics: Virtual medical cannabis clinic offering consultations across Canada
• Tokyo Smoke
• Martha Stewart

Products and services

• Tweed Flagship cannabis brand offering dried flower, pre-rolls, and other cannabis products to recreational and medical consumers globally.
• 7Acres Premium cannabis brand producing high-end dried flower and pre-roll products for cannabis enthusiasts.
• Doja Premium, hand-crafted cannabis flower brand from British Columbia's Okanagan Valley with a West Coast, craft-style positioning.
• Deep Space High-potency cannabis beverage and edible brand offering cola and Limon Splashdown flavours, marketed to experienced consumers.
• Storz & Bickel Vaporizers Premium medical-grade vaporizer devices including Volcano, Mighty, Crafty+, and Volcano Medic 2 models, sold for medical and consumer cannabis vaporization.
• Spectrum Therapeutics International medical cannabis brand with color-coded classification system, offering medical cannabis products to patients and healthcare professionals in Canada, Germany, Australia, UK, Poland, and Czech Republic.
• Wana Edibles Cannabis gummies and edible products offering multiple cannabinoid ratios and terpene formulations.
• Ace Valley Cannabis brand offering ready-to-enjoy cannabis beverages for consumers.
• Twd. Simple, affordable Canadian cannabis brand offering high-quality products for everyday consumers.
• Hiway High-quality, high-value cannabis brand for experienced consumers, including PAX Era pods with cannabis-derived distillate and custom terpene blends.
• LivRelief Infused transdermal creams with proprietary delivery system for CBD and THC, formulated with plant-based ingredients and terpenes.
• Canopy Medical Pharmaceutical manufacturer producing, importing, and releasing medical cannabis products in Germany for patients and healthcare providers.
• Deelish Value-tier cannabis brand offering high-potency (26-33% THC) products at affordable prices, targeting everyday consumers in Ontario and Alberta.
• Claybourne Cannabis brand offering pre-rolls, concentrates, and premium liquid diamond vapes; Frosted Flyers line won 'Best Infused Pre-Roll' at 2026 Grow Up Awards.
• Apollo Cannabis Clinics Virtual medical cannabis consultation service connecting Canadian patients with healthcare practitioners to manage conditions such as chronic pain and anxiety.
• Vert Quebec-exclusive cannabis brand offering strains such as Green Cush and Sour Kush through SQDC retail channels.

Quantifiable outcome

• 27% growth in Canadian medical cannabis net revenue in Q4 FY2026
• +3 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered flagship, core and minor.

• MTL Cannabis Corp.flagshipStrategic or Co-development Partner · 16 March 2026Canopy Growth acquired MTL Cannabis for approximately $125 million CAD (equity value), creating Canada's leading medical cannabis business by revenue. MTL brings cultivation facilities, post-harvest assets, Canada House clinics, and online medical channel. The acquisition closed March 16, 2026, with $10 million in expected annualized synergies within 18 months. Key MTL executives joined Canopy's leadership team.
• ProcapscoreStrategic or Co-development PartnerPartnership with Procaps for formulation and encapsulation of cannabis products in Latin America, establishing Colombia as the regional production hub. Procaps provides formulation and manufacturing capabilities for cannabis-derived products.
• Acreage HoldingscoreStrategic or Co-development PartnerCanopy Growth holds an option to acquire Acreage Holdings upon federal permissibility of THC in the U.S. The arrangement provides Canopy with access to the U.S. cannabis market through Acreage's multi-state operations, with fixed consideration of approximately $300 million plus up to $700 million earnout.
• Wana BrandsminorStrategic or Co-development PartnerCanopy Growth holds an option to acquire Wana Brands upon U.S. federal permissibility of THC. Wana is an award-winning cannabis gummy brand expanding Canopy's edible product capabilities.

Scale indicators6 records

Recent moves7 records

Expansion highlights7 records

Broad incumbents

• Trulieve Cannabis: Trulieve is a leading U.S. multi-state cannabis operator with strong retail density and branded consumer products. Comparable as a large branded cannabis operator; relevant given Canopy's U.S. optionality through Acreage.
• Curaleaf Holdings: Curaleaf is one of the largest U.S. multi-state cannabis operators with a broad branded portfolio across flower, vapes, edibles, and topicals. Relevant as a large-scale MSO peer for Canopy's potential U.S. entry via Acreage, though its U.S.-only focus contrasts with Canopy's international medical footprint.
• Jazz Pharmaceuticals: Jazz Pharmaceuticals acquired GW Pharmaceuticals, the maker of Epidiolex (cannabidiol), establishing a major pharmaceutical presence in cannabinoid-based therapeutics. Comparable to Canopy's medical cannabis and Canopy Medical pharmaceutical manufacturing ambitions in Germany.
• Green Thumb Industries: Green Thumb is a U.S. multi-state cannabis operator with branded consumer products including vapes and edibles. Relevant as a U.S. peer for benchmarking the brand-driven consumer strategy Canopy could deploy if U.S. entry via Acreage materializes.

Direct peers

• Tilray Brands: Tilray is a Canadian-headquartered global cannabis company with diversified branded recreational and medical cannabis operations, plus beverage and wellness adjacencies. It is the closest direct competitor to Canopy in product breadth, international medical footprint, and multi-brand Canadian strategy following its merger with Aphria.
• Aurora Cannabis: Aurora Cannabis is a Canadian licensed producer with global medical cannabis operations across Europe and a Canadian adult-use portfolio. Comparable to Canopy in cultivation scale, medical market focus, and history of significant restructuring and cost reduction efforts.
• Cronos Group: Cronos Group is a Canadian licensed cannabis producer with international operations and consumer brands including Spinach and Peace Naturals. Comparable to Canopy as a publicly traded Canadian LP with multi-brand portfolio and similar restructuring challenges.
• OrganiGram Holdings: OrganiGram is a Canadian cannabis producer focused on premium dried flower, pre-rolls, vapes, and edibles. Comparable to Canopy in serving Canadian adult-use markets with branded product portfolio and pursuing international expansion.
• Aphria (legacy, now part of Tilray): Aphria was a major Canadian cannabis producer with adult-use and medical portfolios and a strong Quebec presence. Highly relevant because Canopy's Chief Business Development Officer previously served as Aphria's CLO, and Aphria's Quebec and medical assets parallel Canopy's post-MTL positioning.

Emerging players

• Demetrix (Amyris subsidiary): Demetrix develops fermented cannabinoid ingredients for pharmaceutical and consumer applications. Comparable as an emerging science-driven cannabis therapeutics player relevant to Canopy's medical and pharmaceutical-grade positioning, particularly in European markets.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/canopy-growth-corporation
• Xx.com/CanopyGrowth

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries8 records

Funding overview

Funding rounds18 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A20 records

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Canopy Growth